Home >> News >> Medicines regulator launches consultation on public involvement in its work

Medicines regulator launches consultation on public involvement in its work

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on how it engages and involves patients and the public in its work.

The MHRA wants to adopt a more systematic approach to listening to and involving patients to ensure the patient voice is heard when safety issues – concerning medicines or medical devices – are identified and in the licensing of new medicines.

The MHRA also wants views on how it can most effectively communicate its work to patients and the public in future.

Patients and patient groups, carers and healthcare professionals are encouraged to respond to the consultation.

The consultation closes on 7 October 2019.